Patents by Inventor Howard Fein

Howard Fein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10463681
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: November 5, 2019
    Assignee: M. ALPHABET 1, L.L.C.
    Inventors: Howard Fein, Mindy B. Berlin
  • Publication number: 20190328802
    Abstract: This disclosure relates to pharmaceutical compositions for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold. The pharmaceutical composition can comprise a probiotic formulation of non-pathogenic bacteria, vitamin C and vitamin D along with a pharmaceutically acceptable excipient or filler. A method of for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold is also disclosed in which a patient in need of a treatment for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold is identified. The pharmaceutical composition can then be administered orally to the patient.
    Type: Application
    Filed: January 17, 2018
    Publication date: October 31, 2019
    Inventors: Howard FEIN, Joshua M. BERLIN
  • Publication number: 20190167074
    Abstract: A wireless medical imaging system comprising a head unit is provided. The head unit comprises a head unit case, an integrated light source, an image sensor, a wireless transceiver, a central processing unit, and a user-input component. The head unit case has an external surface defining an external cavity, an internal surface defining an internal cavity, a first aperture, and a second aperture. The integrated light source, the image sensor, the wireless transceiver, and the central processing unit are disposed within the internal cavity. The integrated light source extends from within the internal cavity into the first aperture and is configured to transmit light from the head unit through the first aperture. The image sensor is configured to detect an image transmitted into the head unit through the second aperture. The external cavity is configured to receive an external battery. The user-input component is disposed on the external surface.
    Type: Application
    Filed: November 16, 2016
    Publication date: June 6, 2019
    Inventors: Eugene Malinskiy, Ilya Malinskiy, Daniel Dudley, Howard Fein, Brad Roskoph
  • Publication number: 20190056537
    Abstract: A virtual reality headset incorporating gradient refractive index (GRIN) lenses within the optical blocks thereof. Optical blocks of varying size and position are used. GRIN lenses are fabricated to fit within the optical block and are shaped to possess desired application-specific characteristics such as having one or more diffractive surfaces.
    Type: Application
    Filed: May 7, 2018
    Publication date: February 21, 2019
    Inventors: HOWARD FEIN, MICHAEL PONTING, RICHARD FLYNN, JAME C. "CHAD" LEWIS, JAMES WELSH
  • Patent number: 10159688
    Abstract: The present invention includes methods and compositions to enhance, inter alia, wound repair by administration of 2,3-biphosphoglycerate, myo-inositol trispyrophosphate, or a functional variant thereof.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 25, 2018
    Assignee: M. ALPHABET 3, L.L.C.
    Inventors: Howard Fein, Joshua M. Berlin
  • Publication number: 20180245775
    Abstract: An integrated light source includes: an emissive radiation source having a first spectrum; an optical element located to direct emissions from the emissive radiation source; a volumetric spectrum converter located to convert emissions directed from the emissive radiation source to emissions having a second spectrum different from the first spectrum; an optical reflector located about the converter; an output filter, the reflector being located to reflect the converter emissions towards the output filter; and a package body having an internal cavity containing the emissive radiation source, optical element, converter, reflector, and filter, wherein desired light radiates from the cavity through the filter.
    Type: Application
    Filed: August 17, 2016
    Publication date: August 30, 2018
    Inventors: Eugene Malinskiy, Ilya Malinskiy, Daniel Dudley, Howard Fein
  • Publication number: 20180153909
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Application
    Filed: February 2, 2018
    Publication date: June 7, 2018
    Inventors: Howard FEIN, Mindy B. Berlin
  • Publication number: 20180085345
    Abstract: The present invention includes compositions and methods for the treatment of skin conditions by administration of a cyclolignan such as picropodophyllin and/or a derivative, metabolite, analog, prodrug, pharmaceutically acceptable salt, or hydrate thereof.
    Type: Application
    Filed: December 4, 2017
    Publication date: March 29, 2018
    Inventors: Howard FEIN, Joshua M. BERLIN
  • Patent number: 9907783
    Abstract: The present invention includes compositions and methods for the treatment of skin conditions by administration of a cyclolignan such as picropodophyllin and/or a derivative, metabolite, analog, prodrug, pharmaceutically acceptable salt, or hydrate thereof.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: March 6, 2018
    Assignee: m.Alphabet 2, LLC
    Inventors: Howard Fein, Joshua M. Berlin
  • Patent number: 9884068
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: February 6, 2018
    Assignee: M. Alphabet 1, LLC
    Inventors: Howard Fein, Mindy B. Berlin
  • Patent number: 9833434
    Abstract: The present invention includes compositions and methods for the treatment of skin conditions by administration of a cyclolignan such as picropodophyllin and/or a derivative, metabolite, analog, prodrug, pharmaceutically acceptable salt, or hydrate thereof.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: December 5, 2017
    Assignee: m. Alphabet 2, L.L.C.
    Inventors: Howard Fein, Joshua M. Berlin
  • Publication number: 20170014433
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Application
    Filed: September 27, 2016
    Publication date: January 19, 2017
    Inventors: Howard FEIN, Mindy B. Berlin
  • Patent number: 9333261
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: May 10, 2016
    Assignee: M. ALPHABET 1, LLC
    Inventors: Howard Fein, Mindy B. Berlin
  • Publication number: 20160038515
    Abstract: The present invention includes methods and compositions to enhance, inter alia, wound repair by administration of 2,3-biphosphoglycerate, myo-inositol trispyrophosphate, or a functional variant thereof.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 11, 2016
    Applicant: M. ALPHABET 3., L.L.C.
    Inventors: Howard FEIN, Joshua M. BERLIN
  • Publication number: 20150231111
    Abstract: The present invention includes compositions and methods for the treatment of skin conditions by administration of a cyclolignan such as picropodophyllin and/or a derivative, metabolite, analog, prodrug, pharmaceutically acceptable salt, or hydrate thereof.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 20, 2015
    Inventors: Howard FEIN, Joshua M. Berlin
  • Publication number: 20150216842
    Abstract: The present invention includes compositions and methods for the treatment of skin conditions by administration of a cyclolignan such as picropodophyllin and/or a derivative, metabolite, analog, prodrug, pharmaceutically acceptable salt, or hydrate thereof.
    Type: Application
    Filed: May 9, 2014
    Publication date: August 6, 2015
    Inventors: Howard Fein, Joshua M. Berlin
  • Publication number: 20140199375
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Application
    Filed: January 17, 2014
    Publication date: July 17, 2014
    Applicant: M. Alphabet 1, LLC
    Inventors: Howard Fein, Mindy B. Berlin
  • Publication number: 20140128351
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Application
    Filed: January 13, 2014
    Publication date: May 8, 2014
    Applicant: M. ALPHABET 1, LLC
    Inventors: Howard Fein, Mindy B. Berlin
  • Patent number: 8692983
    Abstract: Present novel and non-trivial optical, laser-based measuring systems and method are disclosed. An optical, laser-based, or LIDAR measuring apparatus is comprised of a radiation receiver/transmitter, a beam-forming optical element, a beam steering device comprised of a deviation optical element and at least one actuator used to steer the deviation optical element in response to drive signal(s) from a processor.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: April 8, 2014
    Assignee: Rockwell Collins, Inc.
    Inventors: Mark D. Chapman, Wyatt L. Hendrick, Paul N. Smith, Howard Fein
  • Patent number: 8653129
    Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: February 18, 2014
    Assignee: M. Alphabet 1, LLC
    Inventors: Howard Fein, Mindy B. Berlin